RASAL1 is a potent regulator of hepatic stellate cell activity and liver fibrosis-Reference-Cited by-同舟云学术

RASAL1 is a potent regulator of hepatic stellate cell activity and liver fibrosis

Published:2017-05-04 Issue:39 Volume:8 Page:64840-64852
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Takata Akemi¹,Otsuka Motoyuki¹,Kishikawa Takahiro¹,Yamagami Mari¹,Ishibashi Rei¹,Sekiba Kazuma¹,Suzuki Tatsunori¹,Ohno Motoko¹,Yamashita Yui²³,Abe Takaya³,Masuzaki Ryota¹,Ikenoue Tsuneo⁴,Koike Kazuhiko¹

Affiliation:

1. Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

2. Animal Resource Development Unit, RIKEN Center for Life Science Technologies, Kobe, Japan

3. Genetic Engineering Team, RIKEN Center for Life Science Technologies, Kobe, Japan

4. Division of Clinical Genome Research, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endometriotic mesenchymal stem cells promote the fibrosis process of endometriosis through paracrine TGF‐β1 mediated RASAL1 inhibition;Journal of Obstetrics and Gynaecology Research;2023-12-19

2. Theaflavine inhibits hepatic stellate cell activation by modulating the PKA/LKB1/AMPK/GSK3β cascade and subsequently enhancing Nrf2 signaling;European Journal of Pharmacology;2023-10

3. HELLS Is Negatively Regulated by Wild-Type P53 in Liver Cancer by a Mechanism Involving P21 and FOXM1;Cancers;2022-01-17

4. RASAL1 induces to downregulate the SCD1, leading to suppression of cell proliferation in colon cancer via LXRα/SREBP1c pathway;Biological Research;2019-12

5. Advances in the epigenetics of fibroblast biology and fibrotic diseases;Current Opinion in Pharmacology;2019-12